Anti-aging stem cell injection

Intravenous stem cell infusion (ICSI) involves injecting stem cells (such as mesenchymal stem cells, MSCs) into the bloodstream via a vein, allowing the cells to distribute throughout the body and exert repair, immune regulation, and anti-inflammatory effects. It is primarily used in the field of regenerative medicine.

Potential therapeutic effects (based on clinical studies):

Immunomodulation and anti-inflammation: May improve autoimmune diseases (such as systemic lupus erythematosus) and graft-versus-host disease (GVHD; China's first approved stem cell drug, amimetoxetine injection, is used to treat GVHD).

Tissue repair: It can be used as an adjunct treatment for heart failure, stroke, liver disease, and frailty in the elderly, promoting the recovery of cardiac function and reducing inflammation.

Anti-aging potential: Some studies suggest that it can improve fatigue, enhance quality of life, and slow down cellular aging, but the evidence is limited and mainly comes from small-scale trials.

Other: Experimental therapies for the treatment of neurodegenerative diseases such as Parkinson's disease and complications of diabetes.

Non-invasive and convenient: Recovery is faster compared to local injections or surgery.

Whole-body distribution: Cells can "hom" to the site of injury.

High safety profile: Multiple reviews have shown that serious adverse events are rare if the procedure is performed correctly (pulmonary retention is common, but usually asymptomatic).